Colin J. Meyer
Overview
Colin J. Meyer received an average of $2M in total compensation, including $406K in salary, at REATA PHARMACEUTICALS from 2014 to 2021.
2021REATA PHARMACEUTICALSChief Innovation Officer and Executive Vice President
2020REATA PHARMACEUTICALSChief Research and Development Officer and Executive Vice President
2019REATA PHARMACEUTICALSChief Medical Officer and Executive Vice President, Product Development
2018REATA PHARMACEUTICALSChief Medical Officer
2017REATA PHARMACEUTICALSChief Medical Officer
2016REATA PHARMACEUTICALSChief Medical Officer
2015REATA PHARMACEUTICALSChief Medical Officer
2014REATA PHARMACEUTICALSChief Medical Officer
Source: SEC filings on April 29, 2022, April 30, 2021, April 29, 2020, April 30, 2019, April 30, 2018, April 24, 2017, and August 15, 2016.
Related executives
We found six more executives who work or worked at REATA PHARMACEUTICALS.
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
Dawn Bir
REATA PHARMACEUTICALS
Chief Commercial Officer and Executive Vice President
Michael Wortley
REATA PHARMACEUTICALS
Chief Legal Officer
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
Keith Ward
REATA PHARMACEUTICALS
Chief Development Officer
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019